Inactive

This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) inten... This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a IDIQ contract to The Binding Site, Inc, San Diego, CA 92121 on a sole source basis to procure a instrumentation package which includes the following: a) Optilite® fully-automated special protein analyze equipment lease (free rental); b) Reagents (at cost per consumption) and quality controls; c) Maintenance & service warranty to include parts, operational hardware, software upgrade/updates, and user training. The Binding Site is the only vendor/manufacturer that can provide the full test menu required, which includes both the Free Light Chain assay and the CH50 assay, as well as other special proteins needed for patient care testing in the Special Chemistry Service of the Department of Laboratory Medicine. The necessary essays will be utilized for monitoring Clinical Center patients with B cell malignancies. The comprehensive system of the instrument and reagents are necessary to produce complete testing results, without the “PROPRIETARY” reagents patients in the Clinical Center cannot receive the cell therapy care necessary for their treatment per protocols at NIH. Any deviation from the protocol must be reported to the FDA for non-compliance. Department of Laboratory Medicine (DLM) will telephone or e-mail request for reagents and supplies on a needed basis. Period of Performance shall be for a base year of twelve (12) months with four (4) 12 month option periods from date of award. The estimated product list and quantity is attached to this notice and titled – Attachment 1 – List of Supplies 22-001205. The exact quantity of products cannot be estimated at the time of award. The government reserves the right to increase quantities pursuant to FAR 52.217-6. This acquisition is being conducted using policies unique to the contract authority of the test program for commercial items prescribed in FAR Subpart 13.5. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Each response should include the following Business Information: a. DUNS. b. Company Name, address, POC, Phone and Email address c. Current GSA Schedules or NAICS codes appropriate to this Award. d. Type of Company (i.e., small business, 8(a), woman owned, hubZone, veteran owned, etc.) as validated in System For Award Management (SAM). All offerors must register on the SAM located at http://www.sam.gov/portal/SAM/#1 e. Capability Statement Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Malinda Dehner, dehnerm@cc.nih.gov by the due date and time marked in this notice.